PetMed Express, Inc. (PETS) financial statements and ratios from SEC XBRL: revenue $179.02M (TTM), net margin -32.0%, revenue growth -21.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $179.02M |
| Net Margin | -32.0% |
| Revenue Growth (YoY) | -21.1% |
| EPS Growth (YoY) | 813.3% |
| FCF Growth (YoY) | 8256.7% |
| Price / Book | 1.30 |
| Price / Sales | 0.21 |
| FCF Yield | -87.5% |
| Altman Z-Score | 0.29 (distress) |
| Sector P/E (Consumer Discretionary) | 20.5 |
PETS overview · PETS earnings · PETS KPIs · PETS investor relations · PETS ownership · PETS peers · PETS filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.